Home

Plavix

Plavix ineffective in some patients--FDA

Sat, 03/13/2010 - 16:35 by Neka Sehgal

The U.S. Food and Drug Administration (FDA) has added a boxed warning to the anti-clotting medication Plavix, alerting doctors that some patients may not be receiving the full benefits of the drug.

Acid-reducing drugs blunt the benefits of Plavix: FDA

Thu, 11/19/2009 - 12:56 by Jamie Anderson

Orlando, November 19: Combining a class of acid-reducing drugs called proton pump inhibitors (PPIs) with Plavix (clopidogrel), a potent blood-thinner, cuts the Plavix's anti clotting effect by nearly half, rendering heart patients to a greater risk for cardiac arrest and stroke, FDA officials warned.

Blood thinner from Eli Lilly gets FDA nod

Sat, 07/11/2009 - 21:00 by Jamie Anderson

New York, July 11: The Food and Drug Administration (FDA) gave a go ahead to Effient, the highly anticipated blood thinner from the Indiana based Eli Lilly &Company (NYSE: LLY) and Tokyo based Daiichi Sankyo Co. (TYO: 4568)